Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on April 20, 2026

Apr. 20, 2026

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

Indeterminate GlobeNewswire

Apr. 20, 2026

Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

Indeterminate GlobeNewswire

Apr. 20, 2026

Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics

Indeterminate GlobeNewswire

Apr. 20, 2026

$29.6+ BN Life Sciences Consulting Services Market Forecasts to 2034: Rising Drug Complexity, AI & Big Data Adoption, Demand for Real-World Evidence, and Biotech Expansion with Novel Therapies

Indeterminate GlobeNewswire

Apr. 20, 2026

Omega Laboratories to Host Educational Panels and Present Cannabix Marijuana Breath Test Solution at the 2026 NDASA Conference in California

Indeterminate GlobeNewswire

Apr. 20, 2026

Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing

Indeterminate GlobeNewswire

Apr. 20, 2026

Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network

Indeterminate GlobeNewswire

Apr. 20, 2026

When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech

Indeterminate GlobeNewswire

Apr. 20, 2026

PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order

Indeterminate GlobeNewswire

Apr. 20, 2026

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

Indeterminate GlobeNewswire

Apr. 20, 2026

Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years

Indeterminate GlobeNewswire

Apr. 20, 2026

Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter

Indeterminate GlobeNewswire

Apr. 20, 2026

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

Indeterminate GlobeNewswire

Apr. 20, 2026

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

Indeterminate GlobeNewswire

Apr. 20, 2026

Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq

Indeterminate GlobeNewswire

Apr. 20, 2026

COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations

Indeterminate GlobeNewswire

Apr. 20, 2026

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Indeterminate GlobeNewswire